Mirae Asset Global Investments Co. Ltd. Sells 39,005 Shares of DocGo Inc. (NASDAQ:DCGO)

Mirae Asset Global Investments Co. Ltd. lessened its stake in DocGo Inc. (NASDAQ:DCGO) by 18.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 174,467 shares of the company’s stock after selling 39,005 shares during the quarter. Mirae Asset Global Investments Co. Ltd. owned approximately 0.17% of DocGo worth $975,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the company. RFG Advisory LLC raised its stake in shares of DocGo by 155.8% in the third quarter. RFG Advisory LLC now owns 49,676 shares of the company’s stock valued at $265,000 after buying an additional 30,255 shares during the period. Raymond James & Associates bought a new stake in DocGo in the 3rd quarter valued at about $802,000. Trellus Management Company LLC bought a new stake in DocGo in the 3rd quarter valued at about $190,000. Brown Advisory Inc. lifted its holdings in DocGo by 4.6% during the third quarter. Brown Advisory Inc. now owns 432,951 shares of the company’s stock valued at $2,308,000 after purchasing an additional 18,908 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its position in DocGo by 42.5% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,020 shares of the company’s stock worth $128,000 after purchasing an additional 7,166 shares during the period. Hedge funds and other institutional investors own 56.44% of the company’s stock.

Insider Transactions at DocGo

In other news, Director Michael J. Burdiek bought 10,000 shares of DocGo stock in a transaction that occurred on Thursday, March 14th. The shares were acquired at an average price of $3.61 per share, with a total value of $36,100.00. Following the completion of the purchase, the director now directly owns 571,595 shares in the company, valued at $2,063,457.95. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 13.78% of the stock is currently owned by insiders.

DocGo Trading Down 0.3 %

Shares of DCGO opened at $3.50 on Wednesday. The stock has a 50-day moving average price of $3.72 and a 200-day moving average price of $4.61. The company has a market cap of $364.60 million, a PE ratio of 50.00, a price-to-earnings-growth ratio of 0.36 and a beta of 0.91. DocGo Inc. has a 12-month low of $2.78 and a 12-month high of $10.82.

DocGo (NASDAQ:DCGO) last announced its earnings results on Wednesday, February 28th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by ($0.07). DocGo had a net margin of 1.10% and a return on equity of 2.01%. The company had revenue of $199.25 million for the quarter, compared to the consensus estimate of $195.48 million. As a group, analysts predict that DocGo Inc. will post 0.35 earnings per share for the current year.

Wall Street Analyst Weigh In

DCGO has been the topic of a number of recent research reports. Needham & Company LLC dropped their price target on shares of DocGo from $14.00 to $10.00 and set a “buy” rating on the stock in a research note on Thursday, February 29th. BTIG Research dropped their price objective on DocGo from $13.00 to $11.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Cantor Fitzgerald reduced their target price on DocGo from $13.00 to $11.00 and set an “overweight” rating for the company in a report on Thursday, February 29th. Stifel Nicolaus lowered their price target on shares of DocGo from $11.00 to $8.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Finally, Canaccord Genuity Group reduced their price objective on shares of DocGo from $10.00 to $9.00 and set a “buy” rating for the company in a research note on Thursday, April 11th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, DocGo presently has a consensus rating of “Buy” and an average target price of $10.83.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.